# Vensana Capital

> Vensana Capital is a VC fund backing Health Care and Medical Device. See 39 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Minneapolis, United States
- Total investments: 39
- Last investment: Jul 2026
- Lead investor: 59%
- Last fund: Jan 2025
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/vensana-capital
- X (Twitter): https://twitter.com/vensanacapital
- Website: http://vensanacap.com/
- Facebook: https://www.facebook.com/vensanacap

Vensana Capital is a venture capital investment firm that focuses on healthcare with breakthrough innovations in medical technology.

## Contacts

5 contacts available for Vensana Capital. Shizune tracks 8 team members at Vensana Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/vensana-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 19 | 49% |
| Medical Device | 17 | 44% |
| Medical | 13 | 33% |
| Biotechnology | 6 | 15% |
| Wellness | 5 | 13% |

21 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 7 | 18% |
| Series B | 7 | 18% |
| Series C | 4 | 10% |
| Venture - Series Unknown | 3 | 8% |
| Series D | 2 | 5% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 20 | 51% |
| France | 2 | 5% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Aaron Smith | Advisor | 0 | https://shizune.co/investors/profile/aaron-smith-4dea |
| Cynthia Yee | Partner | 4 | https://shizune.co/investors/profile/cynthia-yee |
| Greg Banker | Vice President | 3 | https://shizune.co/investors/profile/greg-banker-5544 |
| Justin Klein | Co-Founder & Managing Partner | 26 | https://shizune.co/investors/profile/justin-klein |
| Kirk Nielsen | Co-Founder & Managing Partner | 3 | https://shizune.co/investors/profile/kirk-nielsen-0ccf |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| TYBR Health | TYBR is a medical device company developing a sprayable hydrogel to keep internal organs scar-free after surgery. Internal scarring is the #1 complication of surgery, and TYBR's naturally derived solution reduces scarring by 75% preclinically. It was founded by Tim Keane and Alex Smith in Houston, Texas in 2020, | $30M | Series A | Jul 21, 2026 |  |
| Ventaris Surgical | Ventaris Surgical is a medical equipment company that provides surgical instruments to specialists. | $30.7M | Series A | Jan 09, 2026 |  |
| Apella Technology | Apella is an AI startup that brings modern engineering to improve surgery. It collects data from operating rooms in hospitals via sensors and puts artificial intelligence to the task of analyzing that information and spits it out in a way that that the startup says can be interpreted by hospitals to improve operations, surgical quality, training,and even real-time decision-making.Apella was founded in 2019 and is headquartered in San Francisco, California. | $80M | Series B | Jan 07, 2026 |  |
| Okami Medical | Okami Medical develops and commercializes new devices for the treatment of heart disease. It was formed to address the evolving needs of patients and physicians through the development of innovative, versatile, and intuitive medical devices for the occlusion of peripheral vessels. Okami believes that vessel occlusion should be rapid and reliableregardless of tortuosity and flow conditions. The LOBO Vascular Occlusion System was developed for this reason.It was founded in 2011 and is headquartered in Aliso Viejo, California. | $45M | Series F | Nov 19, 2025 |  |
| Okami Medical | Okami Medical develops and commercializes new devices for the treatment of heart disease. It was formed to address the evolving needs of patients and physicians through the development of innovative, versatile, and intuitive medical devices for the occlusion of peripheral vessels. Okami believes that vessel occlusion should be rapid and reliableregardless of tortuosity and flow conditions. The LOBO Vascular Occlusion System was developed for this reason.It was founded in 2011 and is headquartered in Aliso Viejo, California. | $45M | Series F | Nov 19, 2025 |  |
| Luna Diabetes | Luna Diabetes is a manufacturer of medical equipment. | $23.6M | Series A | Aug 18, 2025 |  |
| Spyglass Pharma | Spyglass Pharma focuses on the development of novel treatments for chronic ophthalmic diseases based on technology. The company designs to deliver multiple drugs to address additional ophthalmic indications. | $75M | Series D | Jun 02, 2025 |  |
| Evident Vascular | Evident Vascular offers an advanced IVUS platform that leverages Artificial Intelligence to deliver superior Vascular. |  | Series B | Mar 25, 2025 |  |
| Evident Vascular | Evident Vascular offers an advanced IVUS platform that leverages Artificial Intelligence to deliver superior Vascular. |  | Series B | Mar 25, 2025 |  |
| Alleviant Medical | Alleviant Medical focuses on developing a minimally-invasive medical device to treat congestive heart failure. Its proprietary transcatheter technology is designed to create a paradigm shift in the treatment of heart failure by relieving patient symptoms, improving quality of life, and reducing hospital readmissions for over 6 million Americanscurrently suffering from this disease. | $90M | Venture - Series Unknown | Jan 14, 2025 |  |

10 of 39 investments shown.

## Co-investors
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund, 11 deals together
- [Gilde Healthcare](https://shizune.co/investors/profile/gilde-healthcare-partners) — VC Fund, 9 deals together
- [Canaan Partners](https://shizune.co/investors/profile/canaan-partners) — VC Fund, 4 deals together
- [U.S. Venture Partners](https://shizune.co/investors/profile/us-venture-partners) — VC Fund, 4 deals together
- [Endeavour Vision](https://shizune.co/investors/profile/endeavour-vision) — VC Fund, 3 deals together
- [Hatteras Venture Partners](https://shizune.co/investors/profile/hatteras-venture-partners) — VC Fund, 3 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Vensana Capital invest in?

Vensana Capital invests primarily in Health Care, Medical Device and Medical startups, most often at Series A and Series B stage. Most of the 39 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Vensana Capital?

Public channels for Vensana Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Vensana Capital?

The team at Vensana Capital includes Aaron Smith (Advisor), Cynthia Yee (Partner) and Greg Banker (Vice President), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co